Home - Boston Life Sciences Times

LATEST ARTICLES

Real Estate

Brooks Rehabilitation to Open a Rehabilitation Hospital in Lake Nona

Life Sciences Times - December 11, 20200

Public Health

Tychan to Start COVID-19 Phase 3 Clinical Trial For Novel Monoclonal Antibody TY027

Life Sciences Times - December 11, 20200

Biotech

Cell Isolation/ Separation Market Worth $15.0 Billion by 2025

Life Sciences Times - December 11, 20200

Medtech

Roche teams up with Diabeloop to advance the management of insulin pump therapy

Life Sciences Times - December 11, 20200

Life Sciences

US Venture Capital Funding Rose by 33% During the COVID Pandemic; Only Life Sciences and Pharmaceuticals Witnessed Growth

Life Sciences Times - December 11, 20200

Public Health

LabCorp Receives FDA Authorization to Make At-Home COVID-19 Collection Kits Available Through Retail

Life Sciences Times - December 10, 20200

Medtech

Faze Medicines Launches With $81 Million Series A Financing to Leverage New Biology of Biomolecular Condensates to Treat Disease

Life Sciences Times - December 10, 20200

Pharma

Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis

Life Sciences Times - December 10, 20200

Life Sciences

Oxford Finance Provides Credit Facility to DCN Dx

Life Sciences Times - December 10, 20200

Public Health

Tremeau Pharmaceuticals Will Advance Non-Opioid Pain Program with Investment from Gurnet Point Capital

Life Sciences Times - December 9, 20200

1...867868869 870 Page 868 of 870

Suffolk Appoints Bobby Eagar to Lead Orange County Division and Southern California Healthcare Operations

July 13, 2026

Agenus Secures Up to $340 Million to Advance Phase 3 Colon Cancer Trial

July 13, 2026

Charles River to Provide NGS Testing Services for Arovella’s Cancer Cell Therapy Program

July 13, 2026

Cellares and Sonoma Biotherapeutics Partner to Automate Treg Cell Therapy Manufacturing

July 13, 2026

Most Popular

Suffolk Appoints Bobby Eagar to Lead Orange County Division and Southern California Healthcare Operations

Agenus Secures Up to $340 Million to Advance Phase 3 Colon Cancer Trial

Charles River to Provide NGS Testing Services for Arovella’s Cancer Cell Therapy Program

Cellares and Sonoma Biotherapeutics Partner to Automate Treg Cell Therapy Manufacturing

Recent Comments

EDITOR PICKS

Stoke Therapeutics Appoints Thomas McCauley as Chief Scientific Officer

ZETA Surgical Receives FDA Clearance for Robotic TMS System

PODD Investors Alerted to Securities Class Action Against Insulet

THIS WEEK'S STORIES

Biocytogen, Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development

MetaVia Completes Dose Titration in Phase 1 Obesity Study

Vertex to Acquire Crinetics Pharmaceuticals in $10 Billion Deal

POPULAR CATEGORY

ABOUT US

FOLLOW US